These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


144 related items for PubMed ID: 3255911

  • 21. [Resistance of fungi to antifungal antibiotics].
    Drouchet E.
    Pathol Biol; 1967 Dec; 15(23):1222-6. PubMed ID: 4867327
    [No Abstract] [Full Text] [Related]

  • 22. [Antifungal resistance in opportunistic pathogenic fungi (I). Polyenes and fluorocytosine].
    Martínez-Suárez JV, Rodríguez-Tudela JL.
    Enferm Infecc Microbiol Clin; 1996 Dec; 14(6):384-9. PubMed ID: 8756218
    [No Abstract] [Full Text] [Related]

  • 23. Regulation of aromatic metabolism in fungi: selection of mutants of the yeast Rhodotorula mucilaginosa with nystatin.
    Cook KA.
    J Gen Microbiol; 1974 Nov; 85(1):29-36. PubMed ID: 4474355
    [No Abstract] [Full Text] [Related]

  • 24. The effect of nystatin on active transport in Rhodotorula glutinis (gracilis) is restricted to the plasma membrane.
    von Hedenström M, Höfer M.
    Biochim Biophys Acta; 1979 Jul 19; 555(1):169-74. PubMed ID: 573138
    [Abstract] [Full Text] [Related]

  • 25. [The antifungal properties and chemotherapeutic activity of the iso-butyl ester of propane thiosulfonic acid].
    Skorobogat'ko TI.
    Mikrobiol Zh; 1969 Jul 19; 31(6):674-8. PubMed ID: 5408536
    [No Abstract] [Full Text] [Related]

  • 26. [Mode of action of hexachlorocyclohexane isomers in yeast cells].
    Lyr H, Ritter G.
    Z Allg Mikrobiol; 1969 Jul 19; 9(7):545-55. PubMed ID: 4192465
    [No Abstract] [Full Text] [Related]

  • 27. Proceedings: The effect of nystatin on the monosaccharide transport system in Rhodotorula gracilis.
    Heller KB, Höfer M.
    Hoppe Seylers Z Physiol Chem; 1974 Oct 19; 355(10):1203-4. PubMed ID: 4477746
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Resistance problems in treatment of vaginal mycoses? (author's transl)].
    Spitzbart H.
    Zentralbl Gynakol; 1980 Oct 19; 102(9):492-5. PubMed ID: 7467974
    [Abstract] [Full Text] [Related]

  • 34. Pharmacodynamic implications for use of antifungal agents.
    Lewis RE.
    Curr Opin Pharmacol; 2007 Oct 19; 7(5):491-7. PubMed ID: 17616480
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Fungal infections of the eye].
    Schubert E.
    Klin Monbl Augenheilkd; 1970 Mar 19; 156(3):391-4. PubMed ID: 5517977
    [No Abstract] [Full Text] [Related]

  • 37. [The fungicid effect of clodantoin, benzalkonium chloride and sporostacin].
    Becker H, Schweisfurth R.
    Mykosen; 1971 May 01; 14(5):237-43. PubMed ID: 5103527
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Drug resistance in the treatment of invasive fungal infections].
    Nordøy I, Gaustad P.
    Tidsskr Nor Laegeforen; 2008 Nov 20; 128(22):2607-11. PubMed ID: 19023376
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.